dolforin
gedeon richter plc - fentanilis - transderminis pleistras - 50 µg/val; 75 µg/val; 100 µg/val.; 25 µg/val - fentanyl
fluconazole actavis
actavis group ptc ehf. - flukonazolas - kietoji kapsulė - 150 mg - fluconazole
fluconazole baxter
baxter holding b.v. - flukonazolas - infuzinis tirpalas - 2 mg/ml - fluconazole
fluconazole elvim
sia elvim - flukonazolas - kietosios kapsulės - 150 mg - fluconazole
fluconazole ibe
ibe pharma, uab - flukonazolas - infuzinis tirpalas - 2 mg/ml - fluconazole
flucoric
sun pharmaceutical industries europe b. v. - flukonazolas - kietosios kapsulės - 150 mg - fluconazole
linezolid krka
krka, d.d., novo mesto - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
linezolid norameda
norameda, uab - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
xerava
paion deutschland gmbh - eravacycline - infection; bacterial infections - antibacterials sisteminio naudojimo, - xerava fluorouracilu ir folino sudėtingos vidinės pilvo infekcijos (ciai) suaugusiems. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - kiti antineoplastiniai agentai - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.